Article
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
American journal of hematology - 1 May 2003
Pullarkat Vinod A, Bueso-Ramos Carlos, Lai Raymond, Kroft Steven, Wilson Carla S, Pullarkat Sheeja T, Bu Xiangdong, Thein Maung, Lee M, Brynes Russell K
Abstract excerpt
The majority of patients with systemic mastocytosis with associated clonal, hematological non-mast cell lineage disease (SM-AHNMD) have a myeloid stem cell malignancy including myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative disorders, acute myeloid leukemia (AML), or chronic myeloproliferative disease. The clinicopathologic features of SM-AHNMD have not been fully characterized. We describe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
